Multimodal MRI of myalgic encephalomyelitis/chronic fatigue syndrome: A cross-sectional neuroimaging study toward its neuropathophysiology and diagnosis. — CFSMEATLAS
Multimodal MRI of myalgic encephalomyelitis/chronic fatigue syndrome: A cross-sectional neuroimaging study toward its neuropathophysiology and diagnosis.
Shan, Zack Y, Mohamed, Abdalla Z, Andersen, Thu et al. · Frontiers in neurology · 2022 · DOI
Quick Summary
This study used advanced brain imaging to investigate whether ME/CFS is caused by a problem with how the brain's blood vessels respond to neural activity. Researchers scanned the brains of 288 people—including those with ME/CFS, chronic fatigue, fibromyalgia, and healthy controls—while they performed tasks and held their breath, measuring blood flow and brain chemicals. The goal was to find distinctive brain patterns that could objectively diagnose ME/CFS and understand what goes wrong in this disease.
Why It Matters
ME/CFS currently lacks objective diagnostic tests and established biological mechanisms, leaving patients without biomarker confirmation and researchers without clear therapeutic targets. This study addresses both gaps by investigating a plausible neurobiological mechanism and developing a machine learning-based diagnostic tool that could provide patients with objective biological validation and accelerate targeted treatment development. Success could transform ME/CFS from a diagnosis of exclusion to one based on measurable brain physiology.
Observed Findings
Study protocol registered with Australian New Zealand Clinical Trials Registry (ACTRN12622001095752)
Ethics approval obtained from University of the Sunshine Coast (A191288)
Study design includes 288 participants across four groups with standardized diagnostic criteria
Multimodal MRI approach combining hemodynamic, respiratory, and neurochemical measures
Machine learning framework planned for neuromarker development and validation
Inferred Conclusions
Abnormal neurovascular coupling may represent a central neurobiological mechanism in ME/CFS distinct from other chronic fatigue conditions
Objective brain-based biomarkers for ME/CFS diagnosis may be identifiable through multimodal MRI and machine learning approaches
Integrated assessment of blood flow regulation, neural activity, and glutamate signaling could discriminate ME/CFS from chronic fatigue and fibromyalgia
Remaining Questions
Will the identified neuromarker achieve sufficient sensitivity and specificity to be clinically useful for diagnosis?
Do the observed NVC abnormalities differ meaningfully between ME/CFS and other chronic conditions like fibromyalgia and chronic fatigue?
What This Study Does Not Prove
As a protocol paper describing planned methodology rather than results, this study does not yet prove that NVC dysfunction causes ME/CFS—it can only correlate neuroimaging patterns with diagnosis. Even if differences are found, abnormal NVC would be associated with ME/CFS but not necessarily causal. Cross-sectional design cannot establish whether observed brain changes precede symptom onset or result from chronic illness.